There is a woman in Scotland named Jo Cameron who, for nearly eight decades of her life, experienced no pain, anxiety, or sadness. Scientists documented her condition, and researchers published papers examining the genetic mutations behind it. Her remarkable genetic profile, specifically the mutations she carried on two underexplored genes, FAAH and FAAH-OUT, entered the scientific record in 2019. And then, largely, the world’s attention moved on.
Brandon Emerick was 18 years old when he first read about Jo Cameron, and he has not moved on since.
“I knew immediately that her special mutations on the understudied FAAH and FAAH-OUT genes could hold important clues to addressing chronic pain, anxiety, and depression at scale,” he recalls.
The sentence is delivered with complete calm, as though ending global suffering is a perfectly reasonable thing for a college student to place on his to-do list. In his telling, it is.
A Mind Built for This Moment
Brandon’s path to that conclusion began well before age 18. By his own account, he felt pulled toward a meaningful purpose from the age of 10, drawn first to the idea that the internet could transform distant strangers into friends across every border and continent. By 12, that outward pull had turned philosophical and inward. Cognitive science and philosophy became deep preoccupations, not passing hobbies.
He went on to study Cognitive Science and Business Administration at the University of Connecticut, graduating in 2024 magna cum laude with honors. His academic interests in the Free Energy Principle, Self-Determination Theory, and philosophy of mind were not incidental pursuits. They form, as he now understands them, the conceptual foundation for the deeply interdisciplinary work that defines his career today.
In 2019, he became the only undergraduate speaker of the year featured on UConn’s TEDx channel. His talk, “How The Science of Curiosity Can Crush Your Comfort Zone,” was published on YouTube in 2020 and reflected the same intellectual curiosity and interdisciplinary thinking that would later define his work.
The Years Before BlissGene
Before the gene therapy, before the machine-checked proofs, and before the new philosophy of truth, Brandon began his professional life in solar energy at the age of 20.
He was good at it. He ranked among the top salespeople at arranging meetings and pitching potential customers in stores. More than professional experience, those years gave him a clear-eyed view of how resistant people can be to evidence, even when the practical benefits seem obvious. Skepticism about climate change and the imagined costs of solar energy blocked conversations that should have been simple.
“Humans are tremendously irrational,” he concluded, particularly around issues that seem grounded in clear evidence and long-term benefit. It was a formative observation, and it did not discourage him so much as redirect him toward problems he considered both harder and more fundamental.
By 24, he had made a firm decision. His original plan had been to complete a doctorate before founding anything. He set that plan aside. Instead, he moved forward with his bachelor’s degree, hired seven PhD scientists through the professional platform Kolabtree, and established BlissGene Therapeutics, where he now serves as CEO, grounded explicitly in utilitarian conviction: that humanity is obligated to promote wellbeing and eliminate suffering over the long term, as much as possible.
The Gene at the Center of Everything
The science behind BlissGene Therapeutics begins exactly where Brandon’s interest did: with Jo Cameron and the molecular pathway her genetics revealed. Her mutations on the FAAH and FAAH-OUT genes pointed toward a biochemical mechanism underlying chronic pain, anxiety, and depression in ways that conventional medicine has only begun to examine seriously. The company’s aim is to translate those mutations into a gene-therapy platform designed to address chronic pain, anxiety, and depression at their molecular roots.
The scale of the problem that drives this work is not abstract. Chronic pain affects up to half of the world’s population. Anxiety and depression are, by nearly every measure, epidemic. His framing of the situation is frank and deliberate: modern medicine, philosophy, religion, and culture have collectively failed to address what he calls “the central problem of our species” — suffering. He does not say this to be provocative. He says it because the available evidence, as he reads it, supports no gentler conclusion.
BlissGene Therapeutics has met the FDA SBIR administrative-review threshold, an important early milestone for a company operating on a minimal research budget and grounded in the belief that “we ought to promote wellbeing and eliminate suffering over the long term as much as possible.” BlissGene Therapeutics Inc. is actively fundraising with the assistance of two registered broker-dealers and is expected to reach its funding milestones in a matter of months.
A New Architecture for Truth
In June 2025, while actively developing BlissGene and working to secure funding, Brandon launched what he describes as his signature contribution to philosophy, one he invented himself: Tralse Informationalism, formally designated Transcendent Intelligence Sigma, abbreviated as TIΣ.
This dual name is highly intentional: “Tralse Informationalism” provides technical specificity, while “Transcendent Intelligence” offers broader relatability. It is a self-consistent nod to a philosophy that is fundamentally about truth’s ambiguity—the framework itself carries an ambiguous, dual meaning. Furthermore, the “Sigma” aspect refers to the capital Greek letter commonly used to represent “summation.” It is meant to capture the aggregate of all theories associated with the framework, whereas “TI” alone refers strictly to the fundamentally new logic.
The framework challenges the assumption that binary logic alone is sufficient for modeling complex truth states in science and AI. The premise is straightforward, even if its implications are not: binary categories alone are insufficient to capture how truth operates in complex systems.
TIΣ formally identifies five truth values: True, False, Indeterminate, Meta-Indeterminate, and N/A. Beyond these, it introduces what he calls Meta-Truths, among them a category called “Moot,” which describes an agent’s reaction to any of the five base values. Truth, in this system, is not a switch. It is a spectrum.
The framework was tested against Priest’s LP, Belnap-Dunn FDE, and standard binary logic across 500 propositions. Using mutual-information analysis, TIΣ preserved significantly more truth-spectrum information than competing frameworks, recording 1.75 bits compared to 1.42 for FDE, 0.78 for LP, and 0.64 for binary logic. In AI classification tasks, the framework also achieved a Fleiss Kappa score of κ = 0.92, exceeding the κ = 0.80 benchmark commonly considered exemplary for interrater reliability.
“A system can be reliable and uninformative,” he notes. He tested for both, and he is precise about the distinction.
The Standard He Holds Himself To
What makes Brandon’s research program unusual is not simply the breadth of the fields he works across; it is the accountability structure he has built around every claim he makes.
He has developed 20 machine-checked theorems in Lean 4 and mathlib4, covering topics ranging from threshold logic and evaluator injectivity to scalar energy decay and mathematical identities. Submission packets for peer-reviewed venues, including the Archive of Formal Proofs and the Journal of Formalized Reasoning, have already been prepared.
His experimental work also extends into quantum computing. He recorded a 71σ Mermin-inequality violation, with a value of |M₅| = 14.535, on real IBM superconducting hardware, representing the first hardware-confirmed multipartite-entanglement witness in his research corpus.
Across these efforts, he has published more than 100 open-access papers on Zenodo spanning AI, formal logic, statistics, consciousness science, quantum computing, and philosophy of mind — all completed on a minimal research budget.
“I publish my errors as loudly as my successes,” he says. In a research environment that often rewards confident assertions over visible accountability, that sentence carries real weight.
What AI Still Gets Wrong About Itself
The most widespread misconception about AI in healthcare and scientific research, Brandon argues, is the assumption that current systems are already sophisticated enough to evaluate claims reliably. His disagreement operates at the level of architecture, not application.
“With today’s architecture, AI cannot even grade most statements as either true or false to begin with, because truth itself is a spectrum, which binary cannot accommodate, and which even the best existing multi-valued logics fail to capture.”
Responsible innovation in AI, he argues, begins with admitting this limitation openly. Brandon’s research on his 5-valued logic system shows that it has great potential for addressing the ‘AI Hallucination’ epidemic. This is precisely where his formal research and his concerns about AI-driven healthcare intersect: a system built on binary truth evaluation is structurally under-equipped for the genuine complexity of medical and scientific claims. Acknowledging that gap is not pessimism. To him, it is the only honest starting point for building something better.
The Life That Holds It Together
For all the density of his research commitments, Brandon is deliberate about what keeps him grounded. He names two lifelong friends, Alex and Calvin, as steady anchors. Music and family are constants. He watches SpongeBob, asdfmovie, and The Simpsons, and finds in their particular strain of absurd humor a kind of equilibrium that serious scientific work cannot provide on its own.
“Interdisciplinary work is hard, but it is the only kind of work that maps onto how reality actually behaves,” he says. The friendships, humor, and music are not separate from the work. In many ways, they sustain it.
One in a Billion
Jo Cameron’s mutations have been a matter of public scientific record since 2019. Seven years on, in 2026, the work of translating that knowledge into a practical therapeutic reality has barely begun. Brandon does not offer this observation as a complaint. He offers it as a plain description of an open problem, and as the central motivation for everything he has built.
Looking ahead, he sees AI-driven healthcare, formal verification, and therapeutic innovation converging into what he calls “rigorously-validated wellbeing engineering.” BlissGene’s role in that future is to deliver the first generation of gene therapies that minimize baseline human suffering at its molecular root. TIΣ’s role is to provide AI and science with the truth-evaluation architecture they have always needed but never had.
“Rather than saying ‘there’s a one in a billion chance of success if I try,’ you should say: ‘If I DO try, I am one in a billion.’”
Since childhood, he has been building toward a vision that many would consider impossibly ambitious: reducing suffering at its roots through science, formal reasoning, and interdisciplinary research. Through solar marketing and Scottish genetics, machine-checked proofs and a new philosophy of truth, quantum computing, and the stubborn belief that suffering is not inevitable, he has pursued questions most people would consider too large to solve.
In a world where most people wait for certainty before acting, Brandon Emerick built his life’s work around trying anyway.
Quotes
